相关实验视频

Updated: Jun 15, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

确定潜在的MMP-2抑制剂的主要结构属性,其中包括基/基硫基罗利丁基架:一种基于连接体的分子建模方法,通过分子动力学模拟分析验证

S K Baidya¹, S Banerjee¹, B Ghosh²

¹Natural Science Laboratory, Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India.

SAR and QSAR in environmental research

|August 28, 2024

概括

研究人员使用分子建模探索了新的MMP-2抑制剂. 胺基组和硫烯胺基的特定替代剂显示出有望通过向MMP-2开发有效的癌症药物.

科学领域:

药用化学医学化学
分子生物学分子生物学
药物发现药物发现药物发现

背景情况:

矩阵金属蛋白酶-2 (MMP-2) 的过度表达与各种疾病有关,尤其是癌症.
现有的MMP-2抑制剂因副作用而面临挑战,阻碍了临床应用.

研究的目的:

确定用于设计强效MMP-2抑制剂的关键结构特征.
为药物发现验证分子建模和结合模式分析.

主要方法:

使用分子建模对硫烯酸衍生物的计算验证.
结合模式分析以了解MMP-2活性部位内的相互作用.

主要成果:

与酸相比,酸被确定为一种优越的结合组.
确定了终端基部分的有利的疏水和无菌替代物.
这种S1'口袋的适应性和硫基罗利丁核对于MMP-2抑制至关重要.

结论:

这项研究为设计有效的MMP-2抑制剂提供了见解.
确定了具有癌症潜在治疗应用的新型MMP-2抑制剂.
进一步开发可能会导致新的药物候选药物用于疾病管理.

关键词:

贝叶斯的分类是贝叶斯的分类.在COMSIAIA中,我们可以看到.这就是HQSAR.模拟MD的模拟方法在MMP-2中,MMP-2是MMP-2的替代品.分子对接的分子对接.

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

相关概念视频

Molecular Models

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.